Clinical Trials
Catalent Launches New Xpress Pharmaceutics Service to Expedite Development...
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple...
Clinical Trials
Immune Biosolutions reports that its lead immunotherapy product IBIO123...
Immune Biosolutions Inc., a clinical-stage company, is pleased to announce that its leading biological drug candidate maintains a potent activity in neutralization assays. Recent results...
Clinical Trials
Valneva Announces Positive Lot-to-Lot Consistency Trial Results for its...
Valneva SE, a specialty vaccine company, announced positive topline results from the lot-to-lot Phase 3 trial of its single-shot chikungunya vaccine candidate, VLA1553. The VLA1553-302...
Clinical Trials
Valneva Announces Positive Homologous Booster Data for Inactivated, Adjuvanted...
Valneva SE, a specialty vaccine company, announced positive homologous booster data from the Phase 1/2 study, of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001. Initial...
Clinical Trials
CASI Pharmaceuticals And Bioinvent Announce CTA Approval For Clinical...
CASI Pharmaceuticals, Inc., a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announces that the China National Medical Products Administration...
Clinical Trials
Clovers COVID-19 Vaccine Candidate Administered as Heterologous Booster in...
Clover Biopharmaceuticals, Ltd., a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, announced that an investigator-led, Phase 2 trial initiated to evaluate...
Clinical Trials
Emmes Announces Completion of Third ACTT Clinical Trial for...
Emmes announced that it conducted the data and statistical analysis for the third iteration of the Adaptive COVID-19 Treatment Trial (ACTT-3), using its proprietary Advantage...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.